newsfilter
← Latest News
GlobeNewswire·

Stemline Therapeutics Reports Fourth Quarter 2019 Financial Results

Net revenue for ELZONRIS® was $11.8 million for the fourth quarterConference call and live webcast scheduled for Monday, March 16th, at 8:00 AM ET NEW YORK, March 13, 2020 (GLOBE NEWSWIRE) --...